ArticleMolecular therapy oncolytics2016

Reprogramming antitumor immunity against chemoresistant ovarian cancer by a CXCR4 antagonist-armed viral oncotherapy.

Marcin P Komorowski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.